Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis

British Journal of Rheumatology

Volumn 35, Issue 4, 1996, Pages 350-356

  Templ, E ^a,b   Koeller, M ^a   Riedl, M ^a   Wagner, O ^b   Graninger, W ^a   Luger, A ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmunity; Pituitary function; Rheumatoid arthritis

Indexed keywords

CORTICOTROPIN; CYTOKINE; GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; PROLACTIN; RELEASING FACTOR; SEX HORMONE; THYROTROPIN;

ADENOHYPOPHYSIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; ENDOCRINE DISEASE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RHEUMATOID ARTHRITIS; THYROTROPIN BLOOD LEVEL;

EID: 0029868687     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.4.350     Document Type: Article

References (40)

1. Cash JM, Crofford LJ, Gallucci WT et al. Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. J Rheumatol 1992;19:1692-6.
2. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
3. Chikanza IC, Chrousos G, Panayi GS. Abnormal neuroendocrine immune communications in patients with rheumatoid arthritis. Eur J Clin Invest 1992;22:635-7.
4. Hall J, Morand EF, Medbak S et al. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Arthritis Rheum 1994;37:1132-7.
5. Jorgensen C, Bressot N, Lefebre P, Bologna C, Suquet J, Sany J. Dysregulation of pituitary adrenal axis and of prolactin synthesis in rheumatoid arthritis. Arthritis Rheum 1993;36:S175.
6. Jorgensen C, Sany J. Modulation of the immune response by the neuro-endocrine axis in rheumatoid arthritis. Clin Exp Rheum 1994;12:435-41.
7. Folomeev M, Prokaeva T, Nassonova V, Nassonova E, Masenko V, Ovtraht N. Prolactin levels in men with SLE and RA. J Rheumatol 1990;17:1569-70.
8. Neeck G, Federlin K, Graef V, Rusch-D, Schmidt KL. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990;17:24-9.
9. Nagy E, Chalmers IM, Baragar FD, Friesen HG, Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991;18:1662-8.
10. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status and ostgoporosis in postmenopausal women with RA. Arthritis Rheum 1988;31:973-8.
11. Hall GM, Perry LA, Spector TD. Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Ann Rheum Dis 1993;52:211-4.
12. Hedman M, Nilsson E, de la Torre B. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatic arthritis. Clin Exp Rheumatol 1992;10:25-30.
13. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;334:1-5.
14. Sternberg EM, Hill JM, Chrousos GP et al. Inflammatory mediator-induced hypothalamic-pituitary adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-8.
15. Sternberg EM, Young WS, Bernardini R et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771-5.
16. Calogero AE, Sternberg EM, Bagdy G et al. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory diseasesusceptible Lewis rats: In vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 1992;55:600-8.
17. Wilder RL. Corticotropin releasing hormone and the HPA-axis in the regulation of inflammatory arthritis. Agents and Actions 1993;41(suppl.):3-9.
18. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992;117:854-6.
19. Aksentijevich S, Withfield HJ Jr, Young WS. Arthritissusceptible Lewis rats fail to emerge from the stress hyporesponsive period. Brain Res Dev Brain Res 1992;65:115-8.
20. Berczi I, Cosby H, Hunter T, Baragar F, McNeilly AS, Friesen HG. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Br J Rheumatol 1987;26:433-6.
21. Ahmed SA, Penhale WJ, Talal N. Sex hormones and autoimmune diseases: mechanisms of sex hormone action. Am J Pathol 1985;121:531-5.
22. Nelson JL, Steinberg AD. Sex steroids, autoimmunity and autoimmune disease. In: Berczi I, Kovacs K, eds. Hormones and Immunity. Lancaster: MTP Press, 1987.
23. Cohen R, Bouquier D, Biot-Laporte S. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients. J Clin Endocrinol Metab 1986;62:892-8.
24. Schopohl J, Losa M, Koenig A, Mueller OA, Stalla GK, von Werder K. Combined pituitary function test with four hypothalamic releasing hormones. Klin Wochenschr 1986;64:314-6.
25. Schulte HM, Chrousos GP, Oldfield EH, Gold PW, Cutler GB, Loriaux DL. Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening. Harm Res. 1985;21:69-74.
26. Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS. Autoantibody to the nuclear antigen RA33: A marker for early rheumatoid arthritis. Br J Rheumatol 1993;32:199-203.
27. Zacharieva S, Wippermann M, Mucha I, Andonova K, Jankova G. Indomethacin and meclofenamate do not alter ACTH and cortisol responses to corticotropinreleasing hormone in normal subjects. Clin Physiol Biochem 1993;10:28-32.
28. Jara LJ, Lavalle C, Fraga A et al. Prolactin, immunoregulation and autoimmune disease. Semin Arthritis Rheum 1991;20:273-84.
29. Gutierrez MA, Cabrera GE, Cuellar ML, Ctera G, Silveira LH, Espinoza LR. Prolactin induces autoantibody formation by PBL of normal individuals and SLE patients. Arthritis Rheum 1993;36:S197.
30. Mukherjee P, Mastro A, Hymer WC. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 1990;126:88-94.
31. Hednar LP, Bynke G. Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Ophthalmol 1985;4:618-9.
32. Kolodzies-Maciejewska H, Reterski ZP. Effect of bromocriptine treatment of Graves disease orbitopathy. Exp Clin Endocrinol 1985;86:241-2.
33. Bravo G, Zazueta B, Lavalle C. An acute remission of Reiter's syndrome in male patients treated with bromocriptine. J Rheumatol 1992;19:747-50.
34. Spangelo BL, Judd AM, Isakon PC, McLeod RM. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 1989;125:575-7.
35. Madhok R, Crilly A, Watson J, Capell HA. Serum interleukin-6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis 1993;52:232-4.
36. Arvidson NG, Gudbjornsson B, Elfman L, Ryden AC, Totterman TH, Hallgren R. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis 1994;53:521-4.
37. Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Tempi H. Effects of sex and age on growth hormone response to growth hormone releasing hormone in healthy individuals. J Clin Endocrinol Metab 1987;65:535-40.
38. Honeggar J, Spagnoli A, D'urso R et al. Interleukin-1b modulates the acute release of growth-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology 1991;129:1275-82.
39. Scarborough DE, Lee SI, Dinarello CA, Reichlin S. Interleukin-1b stimulates somatostatin biosynthesis in primary culture of fetal rat brain. Endocrinology 1989;124:549-51.
40. Eastgate JA, Symos JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 1988;8613:706-9.